Lung Cancer

Imjudo, Imfinzi and chemotherapy improved overall and progression-free survival in certain patients with non-small cell lung cancer.

New treatments may stall lung cancer progression in patients with EGFR exon 20 insertion mutations.

The Food and Drug Administration approved Libtayo plus chemotherapy for certain patients with non-small cell lung cancer.

Tumors can spread from one lung to the other and beyond. How are possible cancer metastases diagnosed in early stages?

With advancements making a “huge difference” in lung cancer outcomes, one surgical oncologist said that offering his patients hope is the best part of his job.

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

After being diagnosed with mesothelioma, I learned to advocate for myself, and realized that it was an incredibly important life skill to have.

Talking about the end of life can be difficult, but these conversations are crucial for patients with incurable cancer to have with their clinicians, experts say.

After receiving a life-changing lung cancer diagnosis, Alesha Arnold was inspired to give back to her community and improve the lives of patients with the disease.

A man shares how reading the footnote of a CT scan looking for heart disease alerted him to a mass in his right lung, leading to an unexpected diagnosis of lung cancer.

Watch Dr. Hossein Borghaei, Dr. Jessica R. Bauman and Dr. Devika Das answer questions about supportive care during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Devika Das, from University of Alabama at Birmingham Medicine, discuss the benefits of telemedicine in cancer care during the CURE® Educated Patient® Lung Cancer Summit.

A man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.

Watch Dr. Jessica R. Bauman, from Fox Chase Cancer Center, discuss palliative care during the CURE Educated Patient Lung Cancer Summit.

A clinical trial recently kicked off to study the effects of combining the novel drug BBP-398 plus Lumakras in patients with lung cancer that harbors a KRAS G12 mutation.

Watch Dr. Hossein Borghaei, Dr. David Gerber, Dr. Aaron S. Mansfield and Dana M. Haagen answer questions on the management of advanced/metastatic disease during the CURE Educated Patient Lung Cancer Summit.

Watch Dana Haagen, from Fox Chase Cancer Center, discuss clinical trials and how patients can join them, during the CURE® Educated Patient® Lung Cancer Summit.

An expert offers insight into the major treatment improvements over the past 20 years for early-stage and late-stage lung cancer.

Watch Dr. Aaron S. Mansfield, from Mayo Clinic, discuss the management of mesothelioma during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. David Gerber, from UT Southwestern Medical Center, discuss antibody drug conjugates during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. Hossein Borghaei, Dr. Jared Weiss and Dr. Anne Chiang answer questions about early disease management during the CURE Educated Patient Lung Cancer Summit.

Patients with lung cancer must be educated about their disease in their native language to become better advocates for themselves, an expert explained.

I sent all my cancer scans to my pediatrician, who combined the power of science with the power of belief and helped me through the difficult time.

From Kevin Durant’s sneaker that is raising money for cancer to Khloe Kardashian’s urging people to check for moles and melanoma, here’s what’s happening in the cancer space this week.

Watch Dr. Anne Chiang, from Yale School of Medicine, discuss molecular testing and adjuvant targeted therapies during the CURE Educated Patient Lung Cancer Summit.